
无数据
无数据
无数据
| CAS Number | 31430-18-9 |
| Catalog Number | AG00BXYX(AGN-PC-0R6T3N) |
| Chemical Name | Nocodazole |
| EC Number | 250-626-5 |
| IUPAC Name | methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate |
| InChI | InChI=1S/C14H11N3O3S/c1-20-14(19)17-13-15-9-5-4-8(7-10(9)16-13)12(18)11-3-2-6-21-11/h2-7H,1H3,(H2,15,16,17,19) |
| InChI Key | KYRVNWMVYQXFEU-UHFFFAOYSA-N |
| MDL Number | MFCD00005588 |
| Molecular Formula | C14H11N3O3S |
| Molecular Weight | 301.3204 |
| SMILES | O=C(OC)NC1=NC2=CC=C(C(C3=CC=CS3)=O)C=C2N1 |
| UN Number | 2811 |
| UNII | SH1WY3R615 |
| Synonyms | Nocodazole,
NSC 238159,
NSC-238159,
NSC238159,
Oncodazole,
R 17934,
R-17934,
R17934,
nocodazole,
31430-18-9,
Oncodazole,
R 17934,
Nocodazolum,
Nocidazole,
Nocodazol,
NSC 238159,
Nocodazole [USAN:INN],
Nocodazol [INN-Spanish],
Nocodazolum [INN-Latin],
R 17,934,
Methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate,
UNII-SH1WY3R615,
Methyl 5-(2-thenoyl)-2-benzimidazolecarbamate,
Methyl N-(5-thenoyl-2-benzimidazolyl)carbamate,
R17934,
NSC-238159,
Methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate,
R-17934,
C14H11N3O3S,
EINECS 250-626-5,
N-(5-(2-Thenoyl)-2-benzimidazolyl)carbamic acid methyl ester,
NSC238159,
Methyl (5-(2-thienylcarbonyl))-1H-benzimidazole-2-ylcarbamate,
2-Benzimidazolecarbamic acid, 5-(2-thienylcarbonyl)-, methyl ester,
NSC 238 159,
CHEMBL9514,
MLS001164242,
SH1WY3R615,
2-Benzimidazolecarbamic acid, 5-(2-thenoyl)-, methyl ester,
CHEBI:34892,
Methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)carbamate,
methyl (5-(thiophene-2-carbonyl)-1H-benzo[d]imidazol-2-yl)carbamate,
Nocodazole, 98%,
Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester,
MFCD00005588,
API0003615,
NCGC00015647-05,
SMR000326904,
CAS-31430-18-9,
[5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamic acid methyl ester,
Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazole-2-yl)-, methyl ester,
Carbamic acid, [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-, methyl ester,
Methyl 5-(2-thienoyl)-2-benzimidazolecarbamate,
DSSTox_CID_11800,
DSSTox_RID_78890,
DSSTox_GSID_31800,
W-202288,
2-Benzimidazolecarbamic acid, 5-(2-thienoyl)-, methyl ester,
Methyl [5-(2-thienylcarbonyl)-1H- benzimidazol-2-yl]carbamate,
methyl [6-(thiophen-2-ylcarbonyl)-1H-benzimidazol-2-yl]carbamate,
Methyl-[5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamate,
N-(5-(2-Thienoyl)-2-benzimidazolyl)carbamic acid methyl ester,
SR-01000075979,
Nococazole,
Methyl(5-(2-thienylcarbonyl))-1H-benzimidazole-2-yl carbamate,
Methyl[5-(2-thienylcarbonyl)]-1H-benzimidazole-2-yl carbamate,
N-[5-(2-Thenoyl)-2-benzimidazolyl]carbamic acid methyl ester,
N-[5-(2-Thienoyl)-2-benzimidazolyl]carbamic acid methyl ester,
(5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-carbamic acid methyl ester,
Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester (9CI),
Carbamic acid, [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-, methyl ester (9CI),
NZO,
Prestwick_359,
Tocris-1228,
3ee2,
AC1L1HGM,
Nocodazole (USAN/INN),
Prestwick0_000100,
Prestwick1_000100,
Prestwick2_000100,
Prestwick3_000100,
Spectrum3_001768,
Spectrum4_001060,
Lopac-M-1404,
ChemDiv1_000089,
Probes1_000012,
Probes1_000176,
Probes2_000086,
Probes2_000148,
UPCMLD-DP111,
Cambridge id 5175348,
cid_4122,
SCHEMBL9477,
Lopac0_000733,
Oprea1_483899,
Oprea1_741554,
BSPBio_000060,
BSPBio_000982,
BSPBio_003235,
CBDivE_004971,
CBDivE_008428,
JSPY-st000005,
KBioGR_000322,
KBioGR_001360,
KBioSS_000322,
MLS000860046,
BIDD:GT0494,
SPECTRUM1503266,
SPBio_001999,
BPBio1_000066,
DTXSID9031800,
UPCMLD-DP111:001,
BCBcMAP01_000161,
BDBM97233,
CTK8G1974,
HMS587E01,
KBio2_000322,
KBio2_002890,
KBio2_005458,
KBio3_000643,
KBio3_000644,
KBio3_002735,
ZINC56509,
AOB6196,
KYRVNWMVYQXFEU-UHFFFAOYSA-N,
Bio1_000461,
Bio1_000950,
Bio1_001439,
Bio2_000331,
Bio2_000811,
HMS1362B03,
HMS1568C22,
HMS1792B03,
HMS1922O09,
HMS1990B03,
HMS2094G13,
HMS2095C22,
HMS2235E18,
HMS3262C08,
HMS3267F03,
HMS3403B03,
HMS3604E13,
HMS3656J06,
HMS3676A10,
HMS3712C22,
Pharmakon1600-01503266,
BCP07558,
KS-00000XH0,
Tox21_110189,
Tox21_500733,
2593AH,
BN0389,
GP8428,
IN1188,
METHYL-(5-[2-THIENYLCARBONYL]-1H-BENZIMIDAZOL-2YL)CARBAMATE,
NSC759882,
s2775,
STK832483,
Nocodazole, >=99% (TLC), powder,
AKOS000538825,
AKOS015901529,
Tox21_110189_1,
AN-2403,
CCG-101240,
CCG-208075,
CP-0076,
CS-1893,
DB08313,
LP00733,
LS-1178,
MCULE-3133043736,
NSC-759882,
SB19455,
IDI1_002086,
QTL1_000062,
SMP2_000261,
NCGC00015647-01,
NCGC00015647-02,
NCGC00015647-03,
NCGC00015647-04,
NCGC00015647-06,
NCGC00015647-07,
NCGC00015647-08,
NCGC00015647-09,
NCGC00015647-10,
NCGC00015647-11,
NCGC00015647-12,
NCGC00015647-13,
NCGC00015647-14,
NCGC00015647-15,
NCGC00015647-18,
NCGC00025058-01,
NCGC00025058-02,
NCGC00025058-03,
NCGC00025058-04,
NCGC00025058-05,
NCGC00025058-06,
NCGC00025058-07,
NCGC00025058-08,
NCGC00025058-09,
NCGC00025058-10,
NCGC00261418-01,
AC-25615,
AK326024,
AM807900,
BAS 00319017,
HY-13520,
NCI60_001911,
SC-21129,
ST078193,
SBI-0050711.P002,
AB0109635,
EU-0100733,
FT-0660415,
SW102861-5,
C13719,
D05197,
M 1404,
R17,934,
SR-01000075979-1,
SR-01000075979-3,
SR-01000075979-6,
SR-01000075979-9,
BRD-K12539581-001-06-2,
BRD-K12539581-001-14-6,
I14-14250,
methoxy-N-[6-(2-thienylcarbonyl)benzimidazol-2-yl]carboxamide,
methyl 6-(thien-2-ylcarbonyl)-1H-benzimidazol-2-ylcarbamate,
2-Benzimidazolecarbamic acid, 5-(2-thenoyl)-, methyl ester (8CI),
methyl N-(6-thiophen-2-ylcarbonyl-1H-benzimidazol-2-yl)carbamate,
methyl N-[5-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate,
N-[6-(2-thenoyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester,
[[5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]]carbamic acid methyl ester,
[5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]carbonic acid, methyl ester,
carbamic acid, [6-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-, methyl ester,
Carbamic acid, N-[5-(2-thenoyl)-1H-benzimidazol-2-yl]-, methyl ester,
methyl (6-(thiophene-2-carbonyl)-1H-benzo[d]imidazol-2-yl)carbamate,
METHYL [5-(2-THIENYL-CARBONYL)-1H-BENZ-IMIDAZOLE-2-YL]-CARBAMATE,
methyl N-[5-(thiophene-2-carbonyl)-1H-1,3-benzodiazol-2-yl]carbamate,
methyl N-[5-(thiophene-2-carbonyl)-3H-1,3-benzodiazol-2-yl]carbamate,
[5-(Thiophene-2-carbonyl)-1H-benzoimidazol-2-yl]-carbamic acid methyl ester,
[6-(Thiophene-2-carbonyl)-1H-benzoimidazol-2-yl]-carbamic acid methyl ester,
Carbamic acid, N-[6-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]-, methyl ester,
N-[6-[oxo(thiophen-2-yl)methyl]-1H-benzimidazol-2-yl]carbamic acid methyl ester,
Not Available,
Carbamic acid, methyl ester,
CID4122,
Nocodazole, 98% - 10MG 10mg,
C14-H11-N3-O3-S,
2-Benzimidazolecarbamic acid, methyl ester,
A8487,
A13219,
D015739,
|
| Complexity | 420 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 301.052g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 21 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 301.32g/mol |
| Monoisotopic Mass | 301.052g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 112A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.8 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H312-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P261-P280-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

